AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,000 | +6.2% | 12,946 | -18.7% | 0.00% | – |
| Q4 2021 | $112,000 | -36.7% | 15,917 | +2.6% | 0.00% | – |
| Q3 2021 | $177,000 | -43.1% | 15,517 | -20.0% | 0.00% | -100.0% |
| Q2 2021 | $311,000 | +6.9% | 19,407 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $291,000 | +40.6% | 16,295 | +6.1% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | +46.8% | 15,354 | +28.0% | 0.00% | 0.0% |
| Q3 2020 | $141,000 | -23.0% | 11,993 | -3.4% | 0.00% | 0.0% |
| Q2 2020 | $183,000 | -51.8% | 12,412 | -21.1% | 0.00% | -50.0% |
| Q4 2019 | $380,000 | +14.8% | 15,739 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $331,000 | -34.7% | 17,237 | +0.4% | 0.00% | -33.3% |
| Q2 2019 | $507,000 | -44.7% | 17,171 | -11.1% | 0.00% | -40.0% |
| Q1 2019 | $917,000 | +32.7% | 19,309 | +0.8% | 0.01% | 0.0% |
| Q4 2018 | $691,000 | -50.7% | 19,155 | -16.0% | 0.01% | -50.0% |
| Q3 2018 | $1,403,000 | -2.4% | 22,795 | +7.1% | 0.01% | 0.0% |
| Q2 2018 | $1,438,000 | +21.0% | 21,282 | -2.9% | 0.01% | +25.0% |
| Q1 2018 | $1,188,000 | -19.5% | 21,907 | -11.3% | 0.01% | -20.0% |
| Q4 2017 | $1,475,000 | +33.6% | 24,693 | +8.7% | 0.01% | 0.0% |
| Q3 2017 | $1,104,000 | +1.7% | 22,723 | +10.0% | 0.01% | -9.1% |
| Q2 2017 | $1,086,000 | +13.4% | 20,662 | -2.2% | 0.01% | +10.0% |
| Q1 2017 | $958,000 | -5.1% | 21,134 | -20.8% | 0.01% | -9.1% |
| Q4 2016 | $1,010,000 | +34.1% | 26,684 | +33.8% | 0.01% | 0.0% |
| Q3 2016 | $753,000 | +88.7% | 19,949 | -12.1% | 0.01% | +120.0% |
| Q2 2016 | $399,000 | +48.9% | 22,695 | +3.0% | 0.01% | +25.0% |
| Q1 2016 | $268,000 | -54.5% | 22,026 | -8.9% | 0.00% | -42.9% |
| Q4 2015 | $589,000 | +54.2% | 24,189 | +12.2% | 0.01% | +40.0% |
| Q3 2015 | $382,000 | -5.4% | 21,551 | -5.9% | 0.01% | -16.7% |
| Q2 2015 | $404,000 | -39.8% | 22,903 | +7.0% | 0.01% | -25.0% |
| Q1 2015 | $671,000 | +26.8% | 21,407 | +18.0% | 0.01% | +33.3% |
| Q4 2014 | $529,000 | – | 18,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |